Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Exchange Rate Effect (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Exchange Rate Effect for 11 consecutive years, with $11000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 173.33% to $11000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45000.0 through Dec 2025, up 314.29% year-over-year, with the annual reading at $45000.0 for FY2025, 314.29% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $11000.0 at Cartesian Therapeutics, up from -$10000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $115000.0 in Q2 2022, with the low at -$45000.0 in Q4 2022.
  • Average Exchange Rate Effect over 5 years is -$600.0, with a median of -$6500.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect plummeted 650.0% in 2022, then soared 740.0% in 2025.
  • Over 5 years, Exchange Rate Effect stood at -$6000.0 in 2021, then tumbled by 650.0% to -$45000.0 in 2022, then soared by 135.56% to $16000.0 in 2023, then plummeted by 193.75% to -$15000.0 in 2024, then soared by 173.33% to $11000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $11000.0, -$10000.0, and $12000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.